{"entity":{"id":"nct06031246","kind":"trial","name":"Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)","aka":[],"tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting.","summary":"Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) is a phase 3, interventional study registered as NCT06031246 by Fudan University, with a registry enrolment figure of 634 participants, started 2023-04-01 and due to reach its primary completion in 2026-01-01. Interventions recorded: Selective Lymph Node Dissection. Conditions listed: Lung Adenocarcinoma; Lymph Node Metastasis. Primary outcome: 5-year overall survival. Lung eligibility wording from the registry: \"Not receiving lung cancer surgery before;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT06031246","url":"https://clinicaltrials.gov/study/NCT06031246"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-adenocarcinoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06031246","phase":"3","setting":"Selective Lymph Node Dissection for cT1N0M0 Invasive Non-small Cell Lung Cancer With CTR>0.5 Located in the Apical Segment: a Single-arm, Multi-center, Phase III Trial","sponsor":"Fudan University","enrolled":634,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06031246/","neighbours":{"cancer":[{"id":"lung-adenocarcinoma","kind":"cancer","name":"Adenocarcinoma of the lung","route":"/cancers/lung-adenocarcinoma/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}